Found 9 matching trials
ALK21-018: Effects of MedisorbĀ® Naltrexone (VIVITROLĀ®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults PHASE4 This was a study of the effects of VIVITROLĀ® on alcohol cue-induced craving...
Show More Learn More & Join Trial
ALK21-021: A Safety Study of MedisorbĀ® Naltrexone (VIVITROLĀ®) Administered to Health Care Professionals PHASE3 The purpose of this study is to determine the safety and tolerability of Me...
Show More Location
Alkermes Clinical Study Site
Learn More & Join Trial
ALK21-003: Study of MedisorbĀ® Naltrexone (VIVITROLĀ®) in Alcohol-Dependent Adults PHASE3 This was a Phase 3, multicenter, randomized, double-blind, placebo-controll...
Show More Location
Multiple Locations
Learn More & Join Trial
ALK21-014: Efficacy and Safety of MedisorbĀ® Naltrexone (VIVITROLĀ®) After Enforced Abstinence PHASE3 VIVITROL is indicated for the treatment of alcohol dependence in patients w...
Show More Location
Multiple Locations
Learn More & Join Trial
ALK21-013: Efficacy and Safety of MedisorbĀ® Naltrexone (VIVITROLĀ®) in Adults With Opioid Dependence PHASE3 This is a Phase 3 multi-center trial designed to evaluate the clinical effi...
Show More Location
Ethics Committee within the Federal Authority for Healthcare and Social Development Regulation
Learn More & Join Trial
ALK21-006EXT: Long-term Safety of MedisorbĀ® Naltrexone (VIVITROLĀ®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) PHASE3 This was a multicenter extension of Alkermes' Study ALK21-006 (NCT01218997)...
Show More Location
Multiple Locations
Learn More & Join Trial
ALK21-010: Long-term Safety of MedisorbĀ® Naltrexone (VIVITROLĀ®) in Alcohol-dependent Adults PHASE3 This was a Phase 3, multi-center extension of Alkermes' Study ALK21-003EXT ...
Show More Location
Multiple Locations
Learn More & Join Trial
ALK21-006: Long-Term Study of MedisorbĀ® Naltrexone (VIVITROLĀ®) PHASE3 This was a Phase 3 multicenter randomized, open-label, safety study assessi...
Show More Location
Multiple Locations
Learn More & Join Trial
ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of MedisorbĀ® Naltrexone (VIVITROLĀ®) PHASE3 This was a Phase 3 multicenter extension of Alkermes' Study ALK21-003 (NCT0...
Show More Location
Multiple Locations
Learn More & Join Trial